🇺🇸 FDA
Patent

US 9068165

Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer

granted A61KA61K31/7105A61K31/711

Quick answer

US patent 9068165 (Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/7105, A61K31/711, A61K31/713, A61K48/00